<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04652713</url>
  </required_header>
  <id_info>
    <org_study_id>P11-GoDag</org_study_id>
    <nct_id>NCT04652713</nct_id>
  </id_info>
  <brief_title>Breakfast for Young Women</brief_title>
  <acronym>GoDag</acronym>
  <official_title>Breakfast for Young Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Danish Dairy Research Foundation, Denmark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigators will in a crossover study test the health effects of eating a dairy-based&#xD;
      protein-rich breakfast, isocaloric carbohydrate-rich breakfast or no breakfast in young&#xD;
      overweight women. Determination of satiety and hunger using visual analog scores (VAS),&#xD;
      collection of blood samples and 2x 24 hours food logs will be collected.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a single-blind randomized Cross-Over trial with 30 women aged 18-30 years, each&#xD;
      completing three trials. Participants will consume either dairy-based protein-rich breakfast,&#xD;
      isocaloric, fiber matched, fat matched, carbohydrate-rich breakfast or no breakfast in&#xD;
      randomized order. Three hours later a standardized ad libitum lunch will be served.&#xD;
&#xD;
      Blood samples will be collected (pre, 10 min, 30 min, 60 min, 120 min, 175 min after&#xD;
      breakfast) and VAS rating hunger, satiety and desire to eat will be determined (pre, during&#xD;
      breakfast, 10, 30, 60, 90, 120, 180 min, during lunch, after lunch). Twenty-four hour food&#xD;
      logs on the day before the test day and on the test day will be collected.&#xD;
&#xD;
      Participants will be characterized by determining height (cm), weight (kg), and body&#xD;
      composition by a dual-energy X-ray (DXA) scan before the first test day.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 24, 2020</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Single-blind randomized crossover trail with three intervention meals.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Energy consumption on test days</measure>
    <time_frame>0-24 hours</time_frame>
    <description>Total energy consumption on test days (24 hour food log)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in hunger</measure>
    <time_frame>0-3 hours</time_frame>
    <description>Visual Analog Scale (10 cm) score for feeling of hunger</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in satiety</measure>
    <time_frame>0-3 hours</time_frame>
    <description>Visual Analog Scale (10 cm) score for feeling of satiety</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in desire</measure>
    <time_frame>0-3 hours</time_frame>
    <description>Visual Analog Scale (10 cm) score for feeling of desire to eat</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in ghrelin</measure>
    <time_frame>0-3 hours</time_frame>
    <description>in blood sample</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in leptin</measure>
    <time_frame>0-3 hours</time_frame>
    <description>in blood sample</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in glucose-dependent insulinotropic polypeptide (GIP)</measure>
    <time_frame>0-3 hours</time_frame>
    <description>in blood sample</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Peptide YY (PYY3-36)</measure>
    <time_frame>0-3 hours</time_frame>
    <description>in blood sample</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in insulin</measure>
    <time_frame>0-3 hours</time_frame>
    <description>in blood sample</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in glucagon</measure>
    <time_frame>0-3 hours</time_frame>
    <description>in blood sample</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in glucose</measure>
    <time_frame>0-3 hours</time_frame>
    <description>in blood sample</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Energy consumption the day before a test day (food registration)</measure>
    <time_frame>0-24 hours</time_frame>
    <description>Total energy consumption on the day before the test day</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Height</measure>
    <time_frame>Baseline</time_frame>
    <description>Height in cm</description>
  </other_outcome>
  <other_outcome>
    <measure>Weight</measure>
    <time_frame>Baseline</time_frame>
    <description>Weight in kg</description>
  </other_outcome>
  <other_outcome>
    <measure>Body composition fat</measure>
    <time_frame>Baseline</time_frame>
    <description>DXA-scanning to determine fat mass</description>
  </other_outcome>
  <other_outcome>
    <measure>Body composition fat free</measure>
    <time_frame>Baseline</time_frame>
    <description>DXA-scanning to determine fat free mass</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Obesity</condition>
  <condition>Wolman Disease</condition>
  <condition>Nutrition</condition>
  <arm_group>
    <arm_group_label>High protein breakfast</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will be served a dairy-based protein-rich breakfast meal.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High carbohydrate breakfast</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will be served a carbohydrate-rich breakfast meal</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No breakfast</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will be served no breakfast</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Protein-rich breakfast</intervention_name>
    <description>High protein yoghurt containing approx. 10 g protein per 100 g. Participants will be asked to consume 300 g (=3 dl) yoghurt with 40 g oats for breakfast.&#xD;
1 glas of water (150 ml)</description>
    <arm_group_label>High protein breakfast</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Carbohydrate-rich breakfast</intervention_name>
    <description>Low protein breakfast containing approx. 2 g protein per 100 g. Participants will be asked to consume ~60 g bread, 20 g jam and 250 ml juice for breakfast.&#xD;
1 glas of water (150 ml)</description>
    <arm_group_label>High carbohydrate breakfast</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No breakfast</intervention_name>
    <description>1 glas of water (150 ml)</description>
    <arm_group_label>No breakfast</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Body mass index &gt; 25&#xD;
&#xD;
          -  Age 18-25 years&#xD;
&#xD;
          -  Regular exercise &lt; 5 hour per week&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  illness and use of medication affecting the study outcomes&#xD;
&#xD;
          -  allergy towards lactose or gluten&#xD;
&#xD;
          -  weightloss/gain &gt;5kg the last 6 months&#xD;
&#xD;
          -  dieting&#xD;
&#xD;
          -  eating disorder&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  breast feeding&#xD;
&#xD;
          -  unable to speak and understand danish&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mette Hansen, Assoc Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Aarhus</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mette Hansen, PhD</last_name>
    <phone>+45 51666551</phone>
    <email>mhan@ph.au.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Aarhus University, Department for Public Health, Section for Sport Science</name>
      <address>
        <city>Aarhus</city>
        <zip>8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mette Hansen, PhD</last_name>
      <phone>+4551666551</phone>
      <email>mhan@ph.au.dk</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 26, 2020</study_first_submitted>
  <study_first_submitted_qc>November 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 3, 2020</study_first_posted>
  <last_update_submitted>December 15, 2020</last_update_submitted>
  <last_update_submitted_qc>December 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wolman Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

